Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP697860.RAwCx3wXB9CCl2wWJzKnoPWR7o4pjS4kLRRfNG4GtPXdg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP697860.RAwCx3wXB9CCl2wWJzKnoPWR7o4pjS4kLRRfNG4GtPXdg130_assertion type Assertion NP697860.RAwCx3wXB9CCl2wWJzKnoPWR7o4pjS4kLRRfNG4GtPXdg130_head.
- NP697860.RAwCx3wXB9CCl2wWJzKnoPWR7o4pjS4kLRRfNG4GtPXdg130_assertion description "[After stimulation with TLR2 and TLR4 agonists, AVICs express higher levels of pro-inflammatory and pro-osteogenic mediators (bone morphogenetic protein [BMP]-2, runt-related transcription factor 2) and greater osteogenic phenotypic changes (alkaline phosphatase [ALP] activity, calcified nodule formation) than PVICs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP697860.RAwCx3wXB9CCl2wWJzKnoPWR7o4pjS4kLRRfNG4GtPXdg130_provenance.
- NP697860.RAwCx3wXB9CCl2wWJzKnoPWR7o4pjS4kLRRfNG4GtPXdg130_assertion evidence source_evidence_literature NP697860.RAwCx3wXB9CCl2wWJzKnoPWR7o4pjS4kLRRfNG4GtPXdg130_provenance.
- NP697860.RAwCx3wXB9CCl2wWJzKnoPWR7o4pjS4kLRRfNG4GtPXdg130_assertion SIO_000772 19195606 NP697860.RAwCx3wXB9CCl2wWJzKnoPWR7o4pjS4kLRRfNG4GtPXdg130_provenance.
- NP697860.RAwCx3wXB9CCl2wWJzKnoPWR7o4pjS4kLRRfNG4GtPXdg130_assertion wasDerivedFrom befree-20140225 NP697860.RAwCx3wXB9CCl2wWJzKnoPWR7o4pjS4kLRRfNG4GtPXdg130_provenance.
- NP697860.RAwCx3wXB9CCl2wWJzKnoPWR7o4pjS4kLRRfNG4GtPXdg130_assertion wasGeneratedBy ECO_0000203 NP697860.RAwCx3wXB9CCl2wWJzKnoPWR7o4pjS4kLRRfNG4GtPXdg130_provenance.